《港樓》啓德THE HENLEY再推28夥 折實均尺近2.1萬
恆地(00012.HK)位於啓德THE HENLEY第一期、第二期及第三期於過去兩輪銷售共售出114夥,套現近9.4億。恆基物業代理有限公司董事及營業(一)部總經理林達民表示,兩輪銷售均錄多組大手客,而目前整個THE HENLEY系列總更爲集團錄得超過80億進帳。
恆地昨日決定再度推出28夥,並提供高達15%折扣優惠,戶型涵蓋2夥開放式、7夥一房、19夥一房連衣帽間,平均折實尺價20,973元。
當中最低尺價單位爲第1座1樓F室,折實尺價17,969元;最低售價單位爲第3B座37樓F室,折實售價495.6萬元。是次銷售將安排於本週六(14日)以「先到先得」形式推售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.